CLS Holdings USA, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 17 - Stockholders' Equity (Tables)

Note 17 - Stockholders' Equity (Tables)

3 Months Ended

Aug. 31, 2019

Stockholders' Equity Note [Abstract]

Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

The following table summarizes the significant terms of warrants outstanding at August 31, 2019. This table does not include the unit warrants. See Unit Warrants section below.

Range of exercise Prices		Number of warrants Outstanding		Weighted average remaining contractual life (years)		Weighted average exercise price of outstanding Warrants		Number of warrants Exercisable		Weighted average exercise price of exercisable Warrants
$	0.49		33,465,110		2.25	$	0.49		33,465,110	$	0.49
	0.50		2,736,500		2.48		0.50		2,736,500		0.50
	0.60		17,500,000		2.25		0.60		17,500,000		0.60
	0.75		837,500		1.47		0.75		837,500		0.75
	1.10		296,035		2.32		1.10		296,035		1.10
			54,835,145		2.50	$	0.53		54,835,145	$	0.53

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

Transactions involving warrants are summarized as follows. This table does not include the special warrants or unit warrants. See Special Warrants and Unit Warrants sections below.

	Number of Shares			Weighted Average Exercise Price
Warrants outstanding at May 31, 2018		4,497,750		$	0.61
Granted		50,738,235		$	0.53
Exercised		(415,000	)	$	0.75
Cancelled / Expired		-		$	-

Warrants outstanding at May 31, 2019		54,818,985		$	0.53
Granted		16,160		$	1.10
Exercised		-		$	-
Cancelled / Expired		-		$	-
Warrants outstanding at August 31, 2019		54,835,145		$	0.53